USD 25.05
(-0.04%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 122.26 Million | 65.04 Million | 16.1 Million | 33.32 Million | 98.94 Million | 89.53 Million |
Net Income | 91.44 Million | 37.35 Million | -16.42 Million | 452.09 Million | 492.86 Million | 272.9 Million |
Depreciation & Amortization | 17.44 Million | 17.81 Million | 17.77 Million | 20.09 Million | 28.68 Million | 48.7 Million |
Deferred income taxes | 401 Thousand | - | - | -446.87 Million | -415.79 Million | -225.1 Million |
Stock-based compensation | 15.97 Million | 11.93 Million | 15.44 Million | 13.21 Million | 14.42 Million | 19.69 Million |
Change in working capital | -2.5 Million | -2.2 Million | 729 Thousand | -5.42 Million | -21.02 Million | -24.24 Million |
Other non-cash items | -494 Thousand | 141 Thousand | -1.4 Million | 221 Thousand | -214 Thousand | -2.41 Million |
Investing Cash Flow | -5.69 Million | -3.48 Million | -6.8 Million | 643.25 Million | 995.73 Million | 942.12 Million |
Investments in PPE | -5.69 Million | -3.57 Million | -6.8 Million | -12.03 Million | -26.05 Million | -49.93 Million |
Acquisitions | - | 1000.00 | - | -30 Thousand | - | 1000.00 |
Investment purchases | - | 3.47 Million | - | -643.22 Million | - | - |
Sales/Maturities of investments | - | 97 Thousand | - | 655.29 Million | 250 Million | 23.93 Million |
Other Investing Activities | -5.69 Million | -3.48 Million | -6.8 Million | 643.25 Million | 771.78 Million | 918.19 Million |
Financing Cash Flow | -538.26 Million | -280.33 Million | -195.53 Million | -490 Million | -698.13 Million | -988.14 Million |
Debt repayment | - | - | - | -25.44 Million | -255.84 Million | -581.46 Million |
Dividends payments | -476.22 Million | -120.18 Million | -14.01 Million | -435.78 Million | -436.63 Million | -312.6 Million |
Common Stock Repurchased | -60.19 Million | -159.87 Million | -181.48 Million | -26.89 Million | -5.48 Million | -93.97 Million |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -1.84 Million | -279 Thousand | -33 Thousand | -1.87 Million | -170 Thousand | -113 Thousand |
Accounts receivables | -1.73 Million | -6.08 Million | 81 Thousand | -2.11 Million | -13.09 Million | -19.88 Million |
Accounts payables | -401 Thousand | 5.51 Million | -410 Thousand | -3.1 Million | -5.31 Million | -704 Thousand |
Inventory | - | - | 410 Thousand | 3.1 Million | 5.31 Million | - |
Other working capital | -365 Thousand | -1.63 Million | 648 Thousand | -3.3 Million | -7.92 Million | -3.65 Million |
Cash at beginning of period | 2.58 Billion | 2.8 Billion | 2.98 Billion | 2.8 Billion | 2.4 Billion | 2.36 Billion |
Cash at end of period | 2.16 Billion | 2.58 Billion | 2.8 Billion | 2.98 Billion | 2.8 Billion | 2.4 Billion |
Capital Expenditure | -5.69 Million | -3.57 Million | -6.8 Million | -12.03 Million | -26.05 Million | -49.93 Million |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -421.68 Million | -218.77 Million | -186.22 Million | 186.58 Million | 396.54 Million | 43.51 Million |
Free Cash Flow | 116.57 Million | 61.46 Million | 9.3 Million | 21.28 Million | 72.89 Million | 39.6 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -26.22 Million | 24.15 Million | 25.4 Million | 91.44 Million | 26.62 Million | 26.23 Million |
Depreciation & Amortization | 4.29 Million | 4.18 Million | 4.35 Million | 17.44 Million | 4.18 Million | 4.43 Million |
Deferred income taxes | 434 Thousand | -434 Thousand | - | 401 Thousand | - | - |
Stock-based compensation | 2.75 Million | 2.62 Million | 2.56 Million | 15.97 Million | 2.5 Million | 2.49 Million |
Change in working capital | 2.13 Million | 2.12 Million | -9.71 Million | -2.5 Million | 3.05 Million | 2.02 Million |
Other non-cash items | 50.14 Million | 9.44 Million | 20.2 Million | -494 Thousand | -538 Thousand | -107 Thousand |
Investing Cash Flow | -1.78 Million | -5.87 Million | -5.05 Million | -5.69 Million | -1.07 Million | -1.54 Million |
Investments in PPE | 10.92 Million | -5.87 Million | -5.05 Million | -5.69 Million | -1.07 Million | -1.54 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -1.78 Million | -5.87 Million | -5.05 Million | -5.69 Million | -1.07 Million | -1.54 Million |
Financing Cash Flow | -1.99 Million | -2.04 Million | -7.08 Million | -538.26 Million | -2 Million | -58.8 Million |
Debt repayment | - | - | - | - | - | - |
Dividends payments | -1.99 Million | -1.99 Million | -4.03 Million | -476.22 Million | -1.99 Million | -1.99 Million |
Common Stock Repurchased | - | - | -3.05 Million | -60.19 Million | -56.8 Million | -56.8 Million |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | 4.03 Million | -50 Thousand | -4.03 Million | -1.84 Million | 56.8 Million | -56.8 Million |
Accounts receivables | -1.32 Million | 211 Thousand | -793 Thousand | -1.73 Million | -657 Thousand | 441 Thousand |
Accounts payables | 3.39 Million | 1.37 Million | -9.09 Million | -401 Thousand | 6.61 Million | 2.57 Million |
Inventory | - | - | - | - | 401 Thousand | -2.57 Million |
Other working capital | 3.46 Million | 751 Thousand | -617 Thousand | -365 Thousand | -3.3 Million | 1.58 Million |
Cash at beginning of period | 2.19 Billion | 2.17 Billion | 2.16 Billion | 2.58 Billion | 2.12 Billion | 2.15 Billion |
Cash at end of period | 2.22 Billion | 2.19 Billion | 2.17 Billion | 2.16 Billion | 2.16 Billion | 2.12 Billion |
Capital Expenditure | 10.92 Million | -5.87 Million | -5.05 Million | -5.69 Million | -1.07 Million | -1.54 Million |
Effect of forex changes on cash | - | - | - | - | 1.52 Million | 50.09 Million |
Net cash flow / Change in cash | 29.32 Million | 24.98 Million | 10.29 Million | -421.68 Million | 32.74 Million | -25.25 Million |
Free Cash Flow | 44.03 Million | 27.03 Million | 17.38 Million | 116.57 Million | 34.74 Million | 33.54 Million |
GELGF
LOLB
HVW
002403
SUAC
PARNAXLAB